134 related articles for article (PubMed ID: 1478050)
1. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
[TBL] [Abstract][Full Text] [Related]
3. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Bale MJ; Jones RN
J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
5. Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae.
Jones RN; Erwin ME; Washington JA; Koontz FP; Murray PR; Gerlach EH
Diagn Microbiol Infect Dis; 1992; 15(7):627-32. PubMed ID: 1424520
[TBL] [Abstract][Full Text] [Related]
6. MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 Jan; 30(1):225-6. PubMed ID: 1310329
[TBL] [Abstract][Full Text] [Related]
7. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
[TBL] [Abstract][Full Text] [Related]
8. Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Barrett MS; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):462-5. PubMed ID: 1330563
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
LiPuma JJ; Daley B; Stull TL
J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
[TBL] [Abstract][Full Text] [Related]
10. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
12. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
Jones RN; Erwin ME
J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
[TBL] [Abstract][Full Text] [Related]
13. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
Doern GV; Daum GS; Tubert TA
J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738
[TBL] [Abstract][Full Text] [Related]
14. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
Biedenbach DJ; Jones RN
J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Williams JD; Powell M; Fah YS; Seymour A; Yuan M
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
[TBL] [Abstract][Full Text] [Related]
17. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
Jones RN; Barry AL
J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
[TBL] [Abstract][Full Text] [Related]
18. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
19. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
Jones RN; Erwin ME; Gooding BB
J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
[TBL] [Abstract][Full Text] [Related]
20. Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae.
Jones RN; Barrett MS; Biedenbach DJ
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):93-9. PubMed ID: 7805362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
